Potential use of clinical polygenic risk scores in psychiatry - ethical implications and communicating high polygenic risk.

IF 1.9
A C Palk, S Dalvie, J de Vries, A R Martin, D J Stein
{"title":"Potential use of clinical polygenic risk scores in psychiatry - ethical implications and communicating high polygenic risk.","authors":"A C Palk,&nbsp;S Dalvie,&nbsp;J de Vries,&nbsp;A R Martin,&nbsp;D J Stein","doi":"10.1186/s13010-019-0073-8","DOIUrl":null,"url":null,"abstract":"<p><p>Psychiatric disorders present distinct clinical challenges which are partly attributable to their multifactorial aetiology and the absence of laboratory tests that can be used to confirm diagnosis or predict risk. Psychiatric disorders are highly heritable, but also polygenic, with genetic risk conferred by interactions between thousands of variants of small effect that can be summarized in a polygenic risk score. We discuss four areas in which the use of polygenic risk scores in psychiatric research and clinical contexts could have ethical implications. First, there is concern that clinical use of polygenic risk scores may exacerbate existing health inequities. Second, research findings regarding polygenic risk could be misinterpreted in stigmatising or discriminatory ways. Third, there are concerns associated with testing minors as well as eugenics concerns elicited by prenatal polygenic risk testing. Fourth, potential challenges that could arise with the feedback and interpretation of high polygenic risk for a psychiatric disorder would require consideration. While there would be extensive overlap with the challenges of feeding back genetic findings in general, the potential clinical use of polygenic risk scoring warrants discussion in its own right, given the recency of this possibility. To this end, we discuss how lay interpretations of risk and genetic information could intersect. Consideration of these factors would be necessary for ensuring effective and constructive communication and interpretation of polygenic risk information which, in turn, could have implications for the uptake of any therapeutic recommendations. Recent advances in polygenic risk scoring have major implications for its clinical potential, however, care should be taken to ensure that communication of polygenic risk does not feed into problematic assumptions regarding mental disorders or support reductive interpretations.</p>","PeriodicalId":520749,"journal":{"name":"Philosophy, ethics, and humanities in medicine : PEHM","volume":" ","pages":"4"},"PeriodicalIF":1.9000,"publicationDate":"2019-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13010-019-0073-8","citationCount":"75","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Philosophy, ethics, and humanities in medicine : PEHM","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13010-019-0073-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 75

Abstract

Psychiatric disorders present distinct clinical challenges which are partly attributable to their multifactorial aetiology and the absence of laboratory tests that can be used to confirm diagnosis or predict risk. Psychiatric disorders are highly heritable, but also polygenic, with genetic risk conferred by interactions between thousands of variants of small effect that can be summarized in a polygenic risk score. We discuss four areas in which the use of polygenic risk scores in psychiatric research and clinical contexts could have ethical implications. First, there is concern that clinical use of polygenic risk scores may exacerbate existing health inequities. Second, research findings regarding polygenic risk could be misinterpreted in stigmatising or discriminatory ways. Third, there are concerns associated with testing minors as well as eugenics concerns elicited by prenatal polygenic risk testing. Fourth, potential challenges that could arise with the feedback and interpretation of high polygenic risk for a psychiatric disorder would require consideration. While there would be extensive overlap with the challenges of feeding back genetic findings in general, the potential clinical use of polygenic risk scoring warrants discussion in its own right, given the recency of this possibility. To this end, we discuss how lay interpretations of risk and genetic information could intersect. Consideration of these factors would be necessary for ensuring effective and constructive communication and interpretation of polygenic risk information which, in turn, could have implications for the uptake of any therapeutic recommendations. Recent advances in polygenic risk scoring have major implications for its clinical potential, however, care should be taken to ensure that communication of polygenic risk does not feed into problematic assumptions regarding mental disorders or support reductive interpretations.

临床多基因风险评分在精神病学中的潜在应用——伦理意义和传达高多基因风险。
精神疾病呈现出独特的临床挑战,部分原因是其多因素病因和缺乏可用于确认诊断或预测风险的实验室检查。精神疾病是高度遗传性的,但也是多基因的,其遗传风险是由数千种小影响变异之间的相互作用所赋予的,这些变异可以总结为多基因风险评分。我们讨论了在精神病学研究和临床环境中使用多基因风险评分可能具有伦理意义的四个领域。首先,人们担心临床使用多基因风险评分可能会加剧现有的卫生不公平现象。其次,关于多基因风险的研究结果可能被误解为污名化或歧视性的方式。第三,对未成年人的检测以及产前多基因风险检测引起的优生学方面的担忧。第四,对精神疾病高多基因风险的反馈和解释可能带来的潜在挑战需要考虑。虽然反馈遗传发现的挑战在总体上存在广泛的重叠,但考虑到这种可能性最近才出现,多基因风险评分的潜在临床应用本身就值得讨论。为此,我们讨论了对风险和遗传信息的解释是如何交叉的。考虑这些因素对于确保有效和建设性地沟通和解释多基因风险信息是必要的,而多基因风险信息反过来又可能对任何治疗建议的采纳产生影响。多基因风险评分的最新进展对其临床潜力具有重要意义,然而,应注意确保多基因风险的沟通不会导致有关精神障碍的有问题的假设或支持简化的解释。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书